Oncology

Scientists have identified 3 gene variants of HOXD9, which can help explain the development of ovarian cancer.

A Women's Health Initiative clinical trial has found that overweight or obese postmenopausal women are at an increased risk of aggressive breast cancer.

There was a strong connection between the proportion of patients a physician already had enrolled in hospice care and whether or not other patients would enroll in hospice, according to a study published in Health Affairs.

The study found that early palliative care consultations in hospitalized cancer patients significantly reduced the cost of hospital stays.

In the United States, where 1 in 680 people between 20 and 50 years old are survivors of childhood cancer, the impact of long-term health consequences is a cause for concern, and even more so because this population is increasing.

This week CMS released their third round of annual data, the value-based topics of the American Society of Clinical Oncology gained new ground, and The American Journal of Managed Care will travel to their 75th session of the American Diabetes Association in Boston.

Data represented May 18, 2015, at the American Urological Association annual meeting in New Orleans, certainly grabbed headlines.

The report found a 6.5% increase in the compound annual growth rate during the 5-year period leading up to 2014.

BMS has submitted phase 3 results from the CheckMate-066 trial, comparing nivolumab with dacarbazine in treatment-naïve advanced melanoma patients.

Evidence-Based Oncology's editor in chief introduces the special issue on cardio-oncology.

A US appeals court has blocked Novartis from selling the first biosimilar to be approved in the United States.

Will Sandoz' biosimilar, first ever in the US, ever see the light of day?